Taiwan · Delayed Price · Currency is TWD Gongwin Biopharm Holdings Statistics
Total Valuation
TPEX:6617 has a market cap or net worth of TWD 11.77 billion. The enterprise value is 10.27 billion.
| Market Cap | 11.77B |
| Enterprise Value | 10.27B |
Important Dates
The next estimated earnings date is Friday, November 21, 2025.
| Earnings Date | Nov 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6617 has 122.62 million shares outstanding. The number of shares has increased by 10.38% in one year.
| Current Share Class | 122.62M |
| Shares Outstanding | 122.62M |
| Shares Change (YoY) | +10.38% |
| Shares Change (QoQ) | -1.12% |
| Owned by Insiders (%) | 24.80% |
| Owned by Institutions (%) | 0.04% |
| Float | 54.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 341.48 |
| PB Ratio | 4.78 |
| P/TBV Ratio | 4.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -162.72 |
| EV / Sales | 297.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -115.51 |
Financial Position
The company has a current ratio of 12.52, with a Debt / Equity ratio of 0.04.
| Current Ratio | 12.52 |
| Quick Ratio | 11.28 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.20 |
| Interest Coverage | -27.97 |
Financial Efficiency
Return on equity (ROE) is -2.54% and return on invested capital (ROIC) is -3.56%.
| Return on Equity (ROE) | -2.54% |
| Return on Assets (ROA) | -3.41% |
| Return on Invested Capital (ROIC) | -3.56% |
| Return on Capital Employed (ROCE) | -6.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | 3.15 |
Taxes
In the past 12 months, TPEX:6617 has paid 103,000 in taxes.
| Income Tax | 103,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.67% in the last 52 weeks. The beta is 0.27, so TPEX:6617's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -14.67% |
| 50-Day Moving Average | 100.89 |
| 200-Day Moving Average | 102.60 |
| Relative Strength Index (RSI) | 39.47 |
| Average Volume (20 Days) | 140,692 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6617 had revenue of TWD 34.47 million and -63.12 million in losses. Loss per share was -0.50.
| Revenue | 34.47M |
| Gross Profit | 10.88M |
| Operating Income | -174.20M |
| Pretax Income | -73.09M |
| Net Income | -63.12M |
| EBITDA | -165.28M |
| EBIT | -174.20M |
| Loss Per Share | -0.50 |
Balance Sheet
The company has 1.60 billion in cash and 106.28 million in debt, giving a net cash position of 1.49 billion or 12.18 per share.
| Cash & Cash Equivalents | 1.60B |
| Total Debt | 106.28M |
| Net Cash | 1.49B |
| Net Cash Per Share | 12.18 |
| Equity (Book Value) | 2.46B |
| Book Value Per Share | 20.15 |
| Working Capital | 1.66B |
Cash Flow
In the last 12 months, operating cash flow was -81.39 million and capital expenditures -7.52 million, giving a free cash flow of -88.91 million.
| Operating Cash Flow | -81.39M |
| Capital Expenditures | -7.52M |
| Free Cash Flow | -88.91M |
| FCF Per Share | -0.73 |
Margins
Gross margin is 31.56%, with operating and profit margins of -505.33% and -183.09%.
| Gross Margin | 31.56% |
| Operating Margin | -505.33% |
| Pretax Margin | -212.03% |
| Profit Margin | -183.09% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6617 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.38% |
| Shareholder Yield | n/a |
| Earnings Yield | -0.54% |
| FCF Yield | -0.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6617 has an Altman Z-Score of 34.77 and a Piotroski F-Score of 1.
| Altman Z-Score | 34.77 |
| Piotroski F-Score | 1 |